Corix Bioscience (Corix Bioscience) Gross-Profit-to-Asset % : 0.00% (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Corix Bioscience's annualized Gross Profit for the quarter that ended in Sep. 2017 was $0.00 Mil. Corix Bioscience's average Total Assets over the quarter that ended in Sep. 2017 was $7.40 Mil. Therefore, Corix Bioscience's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2017 was 0.00%.

Corix Bioscience Gross-Profit-to-Asset % Historical Data

The historical data trend for Corix Bioscience's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Gross-Profit-to-Asset % Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

6.10

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Corix Bioscience's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corix Bioscience's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Gross-Profit-to-Asset % falls into.

Corix Bioscience Gross-Profit-to-Asset % Calculation

Corix Bioscience's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2016 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2016 )	/	( (Total Assets (A: Jan. 2015 )	+	Total Assets (A: Dec. 2016 ))	/ count )
	=	0.694	/	( (0	+	11.37)	/ 1 )
	=	0.694	/	11.37
	=	6.10 %

Corix Bioscience's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2017 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2017 )	/	( (Total Assets (Q: Jun. 2017 )	+	Total Assets (Q: Sep. 2017 ))	/ count )
	=	0	/	( (10.457	+	4.344)	/ 2 )
	=	0	/	7.4005
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2017) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Corix Bioscience Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines